BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37581620)

  • 41. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes.
    Coomans de Brachène A; Castela A; Op de Beeck A; Mirmira RG; Marselli L; Marchetti P; Masse C; Miao W; Leit S; Evans-Molina C; Eizirik DL
    Diabetes Obes Metab; 2020 Oct; 22(10):1827-1836. PubMed ID: 32476252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes.
    Aida K; Nishida Y; Tanaka S; Maruyama T; Shimada A; Awata T; Suzuki M; Shimura H; Takizawa S; Ichijo M; Akiyama D; Furuya F; Kawaguchi A; Kaneshige M; Itakura J; Fujii H; Endo T; Kobayashi T
    Diabetes; 2011 Mar; 60(3):884-9. PubMed ID: 21289206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
    Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
    J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
    Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.
    Osum KC; Burrack AL; Martinov T; Sahli NL; Mitchell JS; Tucker CG; Pauken KE; Papas K; Appakalai B; Spanier JA; Fife BT
    Sci Rep; 2018 May; 8(1):8295. PubMed ID: 29844327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
    Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
    Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease.
    Reddy S; Krogvold L; Martin C; Holland R; Choi J; Woo H; Wu F; Dahl-Jørgensen K
    Diabetologia; 2018 Jun; 61(6):1362-1373. PubMed ID: 29589071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.
    Campbell-Thompson M; Fu A; Kaddis JS; Wasserfall C; Schatz DA; Pugliese A; Atkinson MA
    Diabetes; 2016 Mar; 65(3):719-31. PubMed ID: 26581594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.
    Dos Santos RS; Guzman-Llorens D; Perez-Serna AA; Nadal A; Marroqui L
    Front Immunol; 2023; 14():1263926. PubMed ID: 37854597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
    Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
    EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function.
    Baumel-Alterzon S; Katz LS; Lambertini L; Tse I; Heidery F; Garcia-Ocaña A; Scott DK
    Diabetologia; 2024 Mar; 67(3):547-560. PubMed ID: 38206362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice.
    Han J; Zhong J; Wei W; Wang Y; Huang Y; Yang P; Purohit S; Dong Z; Wang MH; She JX; Gong F; Stern DM; Wang CY
    Diabetes; 2008 Aug; 57(8):2118-27. PubMed ID: 18477810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetics of TNF-alpha and IFN-gamma mRNA expression in islets and spleen of NOD mice.
    Ventura-Oliveira D; Vilella CA; Zanin ME; Castro GM; Moreira Filho DC; Zollner RL
    Braz J Med Biol Res; 2002 Nov; 35(11):1347-55. PubMed ID: 12426635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon alpha: The key trigger of type 1 diabetes.
    Lombardi A; Tsomos E; Hammerstad SS; Tomer Y
    J Autoimmun; 2018 Nov; 94():7-15. PubMed ID: 30115527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.
    Rabinovitch A; Suarez-Pinzon WL
    Biochem Pharmacol; 1998 Apr; 55(8):1139-49. PubMed ID: 9719467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production.
    Rabinovitch A; Suarez-Pinzon WL; Strynadka K; Lakey JR; Rajotte RV
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3197-202. PubMed ID: 8784069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effect of cytokines and evidence of hyperexpression in IDDM.
    Vives-Pi M; Armengol MP; Alcalde L; Costa M; Somoza N; Vargas F; Jaraquemada D; Pujol-Borrell R
    Diabetes; 1996 Jun; 45(6):779-88. PubMed ID: 8635653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection.
    Campbell IL; Cutri A; Wilkinson D; Boyd AW; Harrison LC
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4282-6. PubMed ID: 2498883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.